aap Implantate AG: Release according to Article 40, Section 1 of the WpHG
(the German Securities Trading Act) with the objective of Europe-wide
distribution

EQS Voting Rights Announcement: aap Implantate AG
aap Implantate AG: Release according to Article 40, Section 1 of the WpHG
(the German Securities Trading Act) with the objective of Europe-wide
distribution

06.06.2024 / 13:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

On June 5, 2024, we informed you pursuant to Section 33 (1) WpHG that the
share of voting rights of Dr. Georg Haindl, Germany, in aap Implantate AG,
Lorenzweg 5, 12099 Berlin, entered in the commercial register of the
Charlottenburg Local Court under HRB 64083, exceeded the threshold of 10% on
June 5, 2024. On this date, the total share of voting rights amounted to
25.44% (corresponding to 2,793,570 voting rights).

Against this background, we inform you of the following pursuant to Section
43 WpHG para. 1:

1. Objectives of the acquisition of the voting rights (Section 43 para. 1
sentences 1 and 3 WpHG)

a) With the investment, the notifying party aims at a longer-term strategic
commitment in aap Implantate AG. However, it should be noted that this is a
predominantly financial investment; there is no investment in the same
industry and economic interests are paramount.

b) The notifying party reserves the right to obtain further voting rights in
the issuer within the next twelve months by acquisition or otherwise should
opportunities arise that are consistent with the objectives of the material
participation.

c) The notifying party intends to exert influence on the composition of
administrative, management and supervisory bodies. In doing so, the
notifying party will enter into a close dialog with the corporate bodies of
aap Implantate AG.

d) The notifying party does not intend to significantly change the capital
structure with regard to the ratio of equity and debt financing of aap
Implantate AG.

2. Origin of the funds used for the acquisition of the voting rights (§ 43
para. 1 sentence 4 WpHG) With regard to the origin of the funds, the
notifying party informs that the acquisition of the voting rights was
financed 100% with own funds.


---------------------------------------------------------------------------

06.06.2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:    English
   Company:     aap Implantate AG
                Lorenzweg 5
                12099 Berlin
                Germany
   Internet:    www.aap.de

End of News EQS News Service
---------------------------------------------------------------------------

1919789 06.06.2024 CET/CEST